Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy

In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nuclear medicine 1994-01, Vol.19 (1), p.64-65
Hauptverfasser: RETTENBACHER, LUKAS, GALVAN, GÜNTHER
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 64
container_title Clinical nuclear medicine
container_volume 19
creator RETTENBACHER, LUKAS
GALVAN, GÜNTHER
description In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.
doi_str_mv 10.1097/00003072-199401000-00018
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76406463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76406463</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2808-7ac7d7bcd8391419500f278c722d14dd53e86debceab701f8e562ff1a911153b3</originalsourceid><addsrcrecordid>eNp1kc-O1DAMxiMEWoaFR0DKAXErJE0naY8w_BmkASR2EcfKTdxp2DTtJqlGfQZeiSfgqchqR9ywZNmWf_osfSaEcvaKs0a9ZjkEU2XBm6ZiPE9FTl4_IBu-FbJgZdk8JBsmpCgaJcvH5EmMPzMhuawuyEXNhdo2bEN-vbN9jwF9spDs5OlbTCdET79htGYBR3fgNQYK3tDrYR2tpvt1xjA7iBao9fQzOHv04BP9MvliP5njjfV_fkd6WMd5mEagP2wa6FXu0hRTPnOnrnFOU6BX2ubTxwDzsD4lj3pwEZ-d6yX5_uH99W5fHL5-_LR7cyjmsmZ1oUArozptatHwijdbxvpS1VqVpeGVMVuBtTTYaYROMd7XuJVl33NoOM_mdOKSvLzXncN0u2BM7WijRufA47TEVsmKyUqKDD4_g0s3omnnYEcIa3t2L-9fnPcQNbg-ZKts_IdVjEnB7mSqe-w0uYQh3rjlhKEdEFwa2v-9UvwFjOaSeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76406463</pqid></control><display><type>article</type><title>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>RETTENBACHER, LUKAS ; GALVAN, GÜNTHER</creator><creatorcontrib>RETTENBACHER, LUKAS ; GALVAN, GÜNTHER</creatorcontrib><description>In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/00003072-199401000-00018</identifier><identifier>PMID: 8137590</identifier><identifier>CODEN: CNMEDK</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Biological and medical sciences ; Child, Preschool ; Citrates ; Citric Acid ; Diagnosis, Differential ; Gallium Radioisotopes ; Hematologic and hematopoietic diseases ; Humans ; Indium Radioisotopes ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, Non-Hodgkin - diagnostic imaging ; Medical sciences ; Octreotide ; Radionuclide Imaging ; Receptors, Somatostatin ; Thymus Hyperplasia - diagnostic imaging</subject><ispartof>Clinical nuclear medicine, 1994-01, Vol.19 (1), p.64-65</ispartof><rights>Lippincott-Raven Publishers.</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4006303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8137590$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RETTENBACHER, LUKAS</creatorcontrib><creatorcontrib>GALVAN, GÜNTHER</creatorcontrib><title>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.</description><subject>Biological and medical sciences</subject><subject>Child, Preschool</subject><subject>Citrates</subject><subject>Citric Acid</subject><subject>Diagnosis, Differential</subject><subject>Gallium Radioisotopes</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Indium Radioisotopes</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, Non-Hodgkin - diagnostic imaging</subject><subject>Medical sciences</subject><subject>Octreotide</subject><subject>Radionuclide Imaging</subject><subject>Receptors, Somatostatin</subject><subject>Thymus Hyperplasia - diagnostic imaging</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc-O1DAMxiMEWoaFR0DKAXErJE0naY8w_BmkASR2EcfKTdxp2DTtJqlGfQZeiSfgqchqR9ywZNmWf_osfSaEcvaKs0a9ZjkEU2XBm6ZiPE9FTl4_IBu-FbJgZdk8JBsmpCgaJcvH5EmMPzMhuawuyEXNhdo2bEN-vbN9jwF9spDs5OlbTCdET79htGYBR3fgNQYK3tDrYR2tpvt1xjA7iBao9fQzOHv04BP9MvliP5njjfV_fkd6WMd5mEagP2wa6FXu0hRTPnOnrnFOU6BX2ubTxwDzsD4lj3pwEZ-d6yX5_uH99W5fHL5-_LR7cyjmsmZ1oUArozptatHwijdbxvpS1VqVpeGVMVuBtTTYaYROMd7XuJVl33NoOM_mdOKSvLzXncN0u2BM7WijRufA47TEVsmKyUqKDD4_g0s3omnnYEcIa3t2L-9fnPcQNbg-ZKts_IdVjEnB7mSqe-w0uYQh3rjlhKEdEFwa2v-9UvwFjOaSeg</recordid><startdate>199401</startdate><enddate>199401</enddate><creator>RETTENBACHER, LUKAS</creator><creator>GALVAN, GÜNTHER</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199401</creationdate><title>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</title><author>RETTENBACHER, LUKAS ; GALVAN, GÜNTHER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2808-7ac7d7bcd8391419500f278c722d14dd53e86debceab701f8e562ff1a911153b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Biological and medical sciences</topic><topic>Child, Preschool</topic><topic>Citrates</topic><topic>Citric Acid</topic><topic>Diagnosis, Differential</topic><topic>Gallium Radioisotopes</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Indium Radioisotopes</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, Non-Hodgkin - diagnostic imaging</topic><topic>Medical sciences</topic><topic>Octreotide</topic><topic>Radionuclide Imaging</topic><topic>Receptors, Somatostatin</topic><topic>Thymus Hyperplasia - diagnostic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RETTENBACHER, LUKAS</creatorcontrib><creatorcontrib>GALVAN, GÜNTHER</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RETTENBACHER, LUKAS</au><au>GALVAN, GÜNTHER</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>1994-01</date><risdate>1994</risdate><volume>19</volume><issue>1</issue><spage>64</spage><epage>65</epage><pages>64-65</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><coden>CNMEDK</coden><abstract>In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>8137590</pmid><doi>10.1097/00003072-199401000-00018</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 1994-01, Vol.19 (1), p.64-65
issn 0363-9762
1536-0229
language eng
recordid cdi_proquest_miscellaneous_76406463
source MEDLINE; Journals@Ovid Complete
subjects Biological and medical sciences
Child, Preschool
Citrates
Citric Acid
Diagnosis, Differential
Gallium Radioisotopes
Hematologic and hematopoietic diseases
Humans
Indium Radioisotopes
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma, Non-Hodgkin - diagnostic imaging
Medical sciences
Octreotide
Radionuclide Imaging
Receptors, Somatostatin
Thymus Hyperplasia - diagnostic imaging
title Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A58%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiation%20Between%20Residual%20Cancer%20and%20Thymic%20Hyperplasia%20in%20Malignant%20Non-Hodgkin%CA%BCs%20Lymphoma%20With%20Somatostatin%20Receptor%20Scintigraphy&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=RETTENBACHER,%20LUKAS&rft.date=1994-01&rft.volume=19&rft.issue=1&rft.spage=64&rft.epage=65&rft.pages=64-65&rft.issn=0363-9762&rft.eissn=1536-0229&rft.coden=CNMEDK&rft_id=info:doi/10.1097/00003072-199401000-00018&rft_dat=%3Cproquest_pubme%3E76406463%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76406463&rft_id=info:pmid/8137590&rfr_iscdi=true